Safety and efficacy of solifenacin in men with OAB [overactive bladder] and detrusor underactivity

Trial Profile

Safety and efficacy of solifenacin in men with OAB [overactive bladder] and detrusor underactivity

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2008

At a glance

  • Drugs Solifenacin (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Jun 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 20 Sep 2007 The expected completion date for this trial is now 1 Jun 2007.
    • 06 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top